204 related articles for article (PubMed ID: 27072687)
1. A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Westerlind H; Stawiarz L; Fink K; Hillert J; Manouchehrinia A
Mult Scler; 2016 Jul; 22(8):1071-9. PubMed ID: 27072687
[TBL] [Abstract][Full Text] [Related]
2. A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry.
Salter A; Thomas NP; Tyry T; Cutter GR; Marrie RA
Mult Scler; 2018 Jun; 24(7):951-962. PubMed ID: 28524746
[TBL] [Abstract][Full Text] [Related]
3. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.
Sumelahti ML; Tienari PJ; Hakama M; Wikström J
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):25-8. PubMed ID: 12486261
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
[TBL] [Abstract][Full Text] [Related]
6. The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry.
Braune S; Bluemich S; Bruns C; Dirks P; Hoffmann J; Heer Y; Rouzic EM; Bergmann A;
BMC Neurol; 2023 Jul; 23(1):258. PubMed ID: 37407914
[TBL] [Abstract][Full Text] [Related]
7. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
8. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resources utilisation in primary progressive multiple sclerosis.
Piccinni C; Ronconi G; Calabria S; Dondi L; Forcesi E; Rossi E; Pedrini A; Martini N
Neurol Sci; 2018 Jul; 39(7):1169-1174. PubMed ID: 29637449
[TBL] [Abstract][Full Text] [Related]
10. Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
de Seze J; Debouverie M; Waucquier N; Steinmetz G; Pittion S; Zephir H; Fleury M; Blanc F; Vermersch P
Mult Scler; 2007 Jun; 13(5):622-5. PubMed ID: 17548441
[TBL] [Abstract][Full Text] [Related]
11. Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Alonso R; Quarracino C; Eizaguirre B; Cohen L; Silva B; Pita C; Rojas JI; Pappolla A; Miguez J; Patrucco L; Cristiano E; Vrech C; Volman G; Silva E; Barboza A; Deri N; Tkachuk V; Zanga G; Tavolini D; Saladino ML; Luetic G; Menichini ML; Carnero Contentti E; López P; Steinberg J; Divi P; Hryb J; Alves Pinheiro A; Carra A; Balbuena ME; Lázaro L; Fernández Liguori N; Garcea O;
Neurol Sci; 2020 Nov; 41(11):3329-3335. PubMed ID: 32840711
[TBL] [Abstract][Full Text] [Related]
12. A systematic review about the epidemiology of primary progressive multiple sclerosis in Latin America and the Caribbean.
Rojas JI; Romano M; Patrucco L; Cristiano E
Mult Scler Relat Disord; 2018 May; 22():1-7. PubMed ID: 29501849
[TBL] [Abstract][Full Text] [Related]
13. Progression rates and sample size estimates for PPMS based on the CLIMB study population.
Raghavan K; Healy BC; Carruthers RL; Chitnis T
Mult Scler; 2015 Feb; 21(2):180-8. PubMed ID: 25070676
[TBL] [Abstract][Full Text] [Related]
14. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Kelly SB; Kinsella K; Duggan M; Tubridy N; McGuigan C; Hutchinson M
Mult Scler; 2013 Jul; 19(8):1095-100. PubMed ID: 23132903
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy in multiple sclerosis: A nationwide population-based register study.
Burman J; Zelano J
Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis.
de Seze J; Devos D; Castelnovo G; Labauge P; Dubucquoi S; Stojkovic T; Ferriby D; Vermersch P
Neurology; 2001 Oct; 57(8):1359-63. PubMed ID: 11673571
[TBL] [Abstract][Full Text] [Related]
17. Disease onset in familial and sporadic primary progressive multiple sclerosis.
Koch M; Zhao Y; Yee I; Guimond C; Kingwell E; Rieckmann P; Sadovnick D; Tremlett H;
Mult Scler; 2010 Jun; 16(6):694-700. PubMed ID: 20378663
[TBL] [Abstract][Full Text] [Related]
18. Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.
Stellmann JP; Neuhaus A; Lederer C; Daumer M; Heesen C
PLoS One; 2014; 9(3):e92761. PubMed ID: 24651401
[TBL] [Abstract][Full Text] [Related]
19. Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.
Thompson A
Mult Scler; 2004 Jun; 10 Suppl 1():S2-7. PubMed ID: 15218803
[TBL] [Abstract][Full Text] [Related]
20. Prodrome in relapsing-remitting and primary progressive multiple sclerosis.
Wijnands JMA; Zhu F; Kingwell E; Zhao Y; Evans C; Fisk JD; Marrie RA; Tremlett H
Eur J Neurol; 2019 Jul; 26(7):1032-1036. PubMed ID: 30714270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
